Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001011438-24-000634
Filing Date
2024-11-13
Accepted
2024-11-13 19:14:35
Documents
1
Group Members
CADIAN CAPITAL MANAGEMENT GP, LLCCADIAN CAPITAL MANAGEMENT, LPERIC BANNASCH

Document Format Files

Seq Description Document Type Size
1 form_sc13ga-maxcyte.htm SC 13G/A 164995
  Complete submission text file 0001011438-24-000634.txt   166941
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Subject) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92738 | Film No.: 241456309
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)

Mailing Address 535 MADISON AVENUE, 36TH FLOOR NEW YORK NY 10022
Business Address 535 MADISON AVENUE, 36TH FLOOR NEW YORK NY 10022 212-792-8800
CADIAN CAPITAL MANAGEMENT, LP (Filed by) CIK: 0001423686 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A